Enterprise Value
$1.76 B
+$21.89 M+1.26%
Wed, 27 Nov 2024 23:28:13 GMT
Summary:
Celldex Therapeutics enterprise value is currently $1.76 billion, with a rise of +$21.89 million (+1.26%) during the most recent trading day. Over the past year, it has increased by +$182.03 million (+11.51%). CLDX enterprise value is now -45.78% below its all-time high of $3.25 billion.CLDX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +1.3% | +1.2% | +1.2% |
| 1 m1 month | -1.5% | -1.5% | -1.5% |
| 3 m3 months | -29.1% | -29.0% | -29.0% |
| 6 m6 months | -24.0% | -26.1% | -26.6% |
| ytdytd | -19.2% | -18.9% | -31.7% |
| 1 y1 year | +11.5% | +12.3% | -7.4% |
| 5 y5 years | +6986.0% | +4661.7% | +1057.7% |
CLDX Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $1.87 B | -5.9% | $1.51 B | +16.6% |
| 3 m | 3 months | $2.92 B | -39.5% | $1.51 B | +16.6% |
| 6 m | 6 months | $2.92 B | -39.5% | $1.51 B | +16.6% |
| 1 y | 1 year | $3.25 B | -45.8% | $1.51 B | +16.6% |
| 3 y | 3 years | $3.25 B | -45.8% | $936 M | +88.5% |
| 5 y | 5 years | $3.25 B | -45.8% | $9.61 M | >+9999.0% |
| alltime | all time | $3.25 B | -45.8% | $1.67 M | >+9999.0% |
Celldex Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $1.76 B(-19.2%) |
| 2023 | $2.18 B(+5.1%) |
| 2022 | $2.08 B(+17.4%) |
| 2021 | $1.77 B(+170.8%) |
| 2020 | $653.50 M(+2058.7%) |
| 2019 | $30.27 M(+161.8%) |
| 2018 | $11.56 M(-96.7%) |
| 2017 | $353.11 M(-8.1%) |
| 2016 | $384.17 M(-74.0%) |
| 2015 | $1.48 B(-8.2%) |
| 2014 | $1.61 B(-19.3%) |
| 2013 | $1.99 B(+376.0%) |
| 2012 | $418.30 M(+253.9%) |
| 2011 | $118.19 M(-2.8%) |
| 2010 | $121.60 M(+33.7%) |
| 2009 | $90.96 M(+12.3%) |
| 2008 | $81.02 M(+151.7%) |
| Date | Value |
|---|---|
| 2007 | $32.19 M(-49.0%) |
| 2006 | $63.13 M(-46.5%) |
| 2005 | $118.09 M(+0.6%) |
| 2004 | $117.43 M(-25.2%) |
| 2003 | $157.05 M(+264.3%) |
| 2002 | $43.11 M(-78.4%) |
| 2001 | $199.71 M(-41.8%) |
| 2000 | $343.00 M(+224.3%) |
| 1999 | $105.77 M(+57.6%) |
| 1998 | $67.10 M(+12.3%) |
| 1997 | $59.74 M(+202.5%) |
| 1996 | $19.75 M(-60.5%) |
| 1995 | $49.94 M(+40.6%) |
| 1994 | $35.52 M(-65.9%) |
| 1993 | $104.17 M(+30.2%) |
| 1992 | $80.03 M(-34.0%) |
| 1991 | $121.33 M(+483.7%) |
| 1990 | $20.79 M |
FAQ
- What is Celldex Therapeutics enterprise value?
- What is the all time high enterprise value for Celldex Therapeutics?
- What is CLDX enterprise value year-to-date change?
- What is Celldex Therapeutics enterprise value year-on-year change?
What is Celldex Therapeutics enterprise value?
The current enterprise value of CLDX is $1.76 B
What is the all time high enterprise value for Celldex Therapeutics?
Celldex Therapeutics all-time high enterprise value is $3.25 B
What is CLDX enterprise value year-to-date change?
Celldex Therapeutics enterprise value has changed by -$420.11 M (-19.24%) since the beginning of the year
What is Celldex Therapeutics enterprise value year-on-year change?
Over the past year, CLDX enterprise value has changed by +$182.03 M (+11.51%)